CareDx, Inc.
Symbol: CDNA (NASDAQ)
Company Description:
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
- Today's Open: $13.243
- Today's High: $13.35
- Today's Low: $13.243
- Today's Volume: 1.59K
- Yesterday Close: $13.33
- Yesterday High: $13.46
- Yesterday Low: $13.1197
- Yesterday Volume: 1.13M
- Last Min Volume: 0
- Last Min High: $13.348
- Last Min Low: $13.341
- Last Min VWAP: $0
- Name: CareDx, Inc.
- Website: https://www.caredx.com
- Listed Date: 2014-07-17
- Location: BRISBANE, CA
- Market Status: Active
- CIK Number: 0001217234
- SIC Code: 8071
- SIC description: SERVICES-MEDICAL LABORATORIES
- Market Cap: $709.52M
- Round Lot: 100
- Outstanding Shares: 53.23M
- Asset Type: CS
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-11 | 4 | View |
| 2025-08-11 | 3 | View |
| 2025-08-07 | 4 | View |
| 2025-08-06 | 10-Q | View |
| 2025-08-06 | 8-K | View |
| 2025-08-05 | 4 | View |
| 2025-08-05 | 144 | View |
| 2025-08-05 | 4 | View |
| 2025-07-24 | SCHEDULE 13G | View |
| 2025-07-14 | 4 | View |
| 2025-07-10 | 4 | View |
| 2025-07-08 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-20 | 4 | View |
| 2025-06-18 | 144 | View |
| 2025-06-17 | 4 | View |
| 2025-06-17 | 4 | View |
| 2025-06-17 | 4 | View |
| 2025-06-17 | 4 | View |
| 2025-06-17 | 4 | View |